Search research articles
Contact Us
Filters
Showing results (21-30 of 248) with videos related to
Page
of 25
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2014
Coffee: a panacea or snake oil for the liver?
Radhika Kumari, W Ray Kim
European Journal of Gastroenterology & Hepatology
|
May 29, 2004
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
Kiran Bambha, W Ray Kim
The American Journal of Gastroenterology
|
May 21, 2009
Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander?
Byung Cheol Yun, W Ray Kim
Gastroenterology
|
February 24, 2010
Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studies
Sumeet K Asrani, W Ray Kim
Health Economics
|
August 31, 2002
Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation
David J Vanness, W Ray Kim
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 25, 2011
Surveillance for hepatocellular carcinoma in patients with cirrhosis
Ju Dong Yang, W Ray Kim
Clinical Liver Disease
|
April 17, 2019
Epidemiology of Hepatitis B Virus Infection in the United States
Bo Hyun Kim, W Ray Kim
Gastroenterology
|
August 26, 2010
Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny?
Michael D Leise, W Ray Kim
Clinics in Liver Disease
|
October 5, 2002
Medical and economic impact of autoimmune hepatitis
Jayant A Talwalkar, W Ray Kim
Clinics in Liver Disease
|
January 20, 2009
The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure
Patrick S Kamath, W Ray Kim
Page
of 25
Search research articles
Search
Showing results (21-30 of 248) with videos related to
Sort By:
Page
of 25
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2014
Coffee: a panacea or snake oil for the liver?
Radhika Kumari, W Ray Kim
European Journal of Gastroenterology & Hepatology
|
May 29, 2004
Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
Kiran Bambha, W Ray Kim
The American Journal of Gastroenterology
|
May 21, 2009
Hyponatremia in hepatic encephalopathy: an accomplice or innocent bystander?
Byung Cheol Yun, W Ray Kim
Gastroenterology
|
February 24, 2010
Predicting response to pegylated interferon/ribavirin-based therapy in genotype 1 chronic hepatitis C patients: results of 3 independent genome-wide association studies
Sumeet K Asrani, W Ray Kim
Health Economics
|
August 31, 2002
Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation
David J Vanness, W Ray Kim
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 25, 2011
Surveillance for hepatocellular carcinoma in patients with cirrhosis
Ju Dong Yang, W Ray Kim
Clinical Liver Disease
|
April 17, 2019
Epidemiology of Hepatitis B Virus Infection in the United States
Bo Hyun Kim, W Ray Kim
Gastroenterology
|
August 26, 2010
Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny?
Michael D Leise, W Ray Kim
Clinics in Liver Disease
|
October 5, 2002
Medical and economic impact of autoimmune hepatitis
Jayant A Talwalkar, W Ray Kim
Clinics in Liver Disease
|
January 20, 2009
The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure
Patrick S Kamath, W Ray Kim
Page
of 25